These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6664892)

  • 1. [Changes in serum fucose and sialic acid contents and the course of malignant ovarian neoplasms].
    Jaskulska T; Markowska J; Manyś G; Branowski M
    Nowotwory; 1983; 33(3):203-8. PubMed ID: 6664892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K; Breborowicz J
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary evaluation of the usefulness of determination of blood serum fucose and sialic acid level in women with genital tumors].
    Simm S; Markowska J; Tomaszkiewicz T; Herwichowska K
    Ginekol Pol; 1979 Nov; 50(11):957-63. PubMed ID: 544355
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical markers in ovarian cancer.
    Kiricuta I; Bojan O; Munteanu S
    Arch Geschwulstforsch; 1986; 56(1):35-8. PubMed ID: 3964031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S; Senthil K; Nalini N
    Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between the contents of sialic acid and fucose on red cell membrane and occurrence of atrophic gastritis and gastric cancer].
    Sun YX
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):346-8. PubMed ID: 3248500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with gynecologic cancer by serum sialic acid determination.
    Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
    Gynecol Oncol; 1989 May; 33(2):231-6. PubMed ID: 2703183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary.
    Silver HK; Karim KA; Salinas FA; Swenerton KD
    Surg Gynecol Obstet; 1981 Aug; 153(2):209-13. PubMed ID: 7244990
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers.
    Turner GA; Skillen AW; Buamah P; Guthrie D; Welsh J; Harrison J; Kowalski A
    J Clin Pathol; 1985 May; 38(5):588-92. PubMed ID: 2582003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
    Warwas M; Dobryszycka W; Gerber J; Pietkiewicz A
    Neoplasma; 1981; 28(4):485-90. PubMed ID: 7290269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on assay method for fucose and sialic acid contents in sputum and serum of patients with lung diseases].
    Fujisawa K; Yasuoka S; Tatenuma Y; Noda Y; Nakanishi Y; Nii Y; Ozaki T; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jun; 26(6):658-64. PubMed ID: 3241505
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of serum fucose, sialic acid, haptoglobine and phospholipids levels in the evolution and treatment of breast cancer.
    Kiricuta I; Bojan O; Comes R; Cristian R
    Arch Geschwulstforsch; 1979; 49(2):106-12. PubMed ID: 475547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sialic acid is a biologic marker for malignant disease.
    Khanderia U; Keller JH; Grossman HB
    J Surg Oncol; 1983 Jul; 23(3):163-6. PubMed ID: 6865437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential quantitative changes of N-acetylneuraminic acid and L-fucose in the blood of patients with diabetes mellitus and other intercurrent diseases].
    Torres Gallardo J; Luna Lagunes M; Sanchez Castillo J; Aguirre Gas H
    Prensa Med Mex; 1977; 42(3-4):120-6. PubMed ID: 917990
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness and potential pitfalls of sialic acid determination in sera of patients with ovarian tumors.
    Berra B; Rapelli S; Monticelli G; Fighetti MA; Della Mea I; Raspagliesi F; Di Re E; Ringhini R; Bombardieri E
    Int J Biol Markers; 1986; 1(1):39-46. PubMed ID: 3693972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum lipid-bound sialic acid assay for detection of ovarian neoplasm].
    Chen SP
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):235-8. PubMed ID: 6675922
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
    Patsner B; Mann WJ; Vissicchio M; Loesch M
    Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in serum sialic acid levels in patients with ovarian tumors in the process of treatment].
    Travnikov ME; Novikov AM; Varazashvili LM; Bassalyk LS; Kozachenko VP
    Akush Ginekol (Mosk); 1990 Jul; (7):61-3. PubMed ID: 2240453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.